Technical / White Paper

DRcaps® capsules achieve delayed release properties for nutritional ingredients in human clinical study

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Capsugel , and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

Capsugel

A gamma scintigraphic study of DRcaps®​ capsules  in human subjects definitively documents that the specially formulated acid-resistant hydroxypropyl methylcellulose (HPMC) capsules are an “excellent choice” for delayed delivery of acid-sensitive ingredients like probiotics and enzymes. Data and images empirically demonstrate the capsules’ effective protection from early activation caused by stomach acids and, for a majority of study subjects, complete release in intestines where products such as probiotics and enzymes work best.

Supplier info centre